Market Currents
Valeant Pharmaceuticals (VRX +3.2%) trades higher as the Street comments on an upbeat analyst...
-
Friday, June 22, 2012, 11:52 AM ETValeant Pharmaceuticals (VRX +3.2%) trades higher as the Street comments on an upbeat analyst day, one that saw the drug developer raise its 2012 guidance to the high end of prior ranges. Jefferies (Buy) declares Valeant to be an "excellent," albeit "controversial" investment, and is impressed with its guidance in light of the company's 20%+ Euro exposure.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
